Yes. We’ll build A so that B is an additive shell, not a rewrite:

```text
Synthetic case → evidence extraction → line-level findings → analyst decision
                                                              ↑
                                   B later adds: queue + exposure totals + 24 more cases
```

**Pivot gate:** only start B after the full A walkthrough works locally with deterministic results: case opens, findings are ranked, every finding has source evidence, and the review decision is recorded. Otherwise, spend the remaining time polishing A and the pitch.

### D5 — Confirm the product guardrails

Reply with **A, B, or C**.

ELI10: These guardrails keep the demo credible. A product that calls a claim “fraud” from writing style alone will look reckless. A product that shows an analyst exactly what is unsupported and preserves the source evidence looks like a safe, practical first wedge.

Recommendation: **A** because it gives us a differentiated, buildable demo and an honest path to a real product.

A) **Accept all guardrails** *(recommended)*. Note: options differ in kind, not coverage — no completeness score. Use only synthetic, non-PHI cases; call findings “hold for analyst review,” never automated denials or fraud determinations; require a source-cited evidence gap for each finding; and add B only after A passes the pivot gate.

B) **Keep the evidence-first workflow, but allow a stronger fraud claim.** Note: options differ in kind, not coverage — no completeness score. The pitch can use “AI-generated documentation risk,” but the UI still avoids declaring fraud. This is punchier but needs careful language.

C) **Change the premise.** Note: options differ in kind, not coverage — no completeness score. Tell me which boundary should change: synthetic data, human review, evidence citation, or the A→B pivot gate.

Net: the moat is the evidence chain and future feedback data, not claiming a magical fraud detector.